Astellas Pharma Inc (ALPMY)
10.70
0.00 (0.00%)
USD |
OTCM |
Nov 15, 16:00
Astellas Pharma Market Cap: 19.15B for Nov. 15, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 14, 2024 | 19.15B |
| November 13, 2024 | 19.22B |
| November 12, 2024 | 19.55B |
| November 11, 2024 | 20.06B |
| November 08, 2024 | 19.99B |
| November 07, 2024 | 20.23B |
| November 06, 2024 | 19.99B |
| November 05, 2024 | 20.40B |
| November 04, 2024 | 20.96B |
| November 01, 2024 | 20.87B |
| October 31, 2024 | 20.91B |
| October 30, 2024 | 22.01B |
| October 29, 2024 | 20.83B |
| October 28, 2024 | 20.18B |
| October 25, 2024 | 20.30B |
| October 24, 2024 | 20.62B |
| October 23, 2024 | 20.48B |
| October 22, 2024 | 20.89B |
| October 21, 2024 | 21.06B |
| October 18, 2024 | 21.00B |
| October 17, 2024 | 20.64B |
| October 16, 2024 | 20.42B |
| October 15, 2024 | 20.53B |
| October 14, 2024 | 20.91B |
| October 11, 2024 | 20.96B |
| Date | Value |
|---|---|
| October 10, 2024 | 21.19B |
| October 09, 2024 | 20.85B |
| October 08, 2024 | 20.98B |
| October 07, 2024 | 20.96B |
| October 04, 2024 | 20.89B |
| October 03, 2024 | 20.76B |
| October 02, 2024 | 20.49B |
| October 01, 2024 | 20.37B |
| September 30, 2024 | 20.49B |
| September 27, 2024 | 21.25B |
| September 26, 2024 | 21.33B |
| September 25, 2024 | 21.39B |
| September 24, 2024 | 21.46B |
| September 23, 2024 | 21.78B |
| September 20, 2024 | 21.64B |
| September 19, 2024 | 21.75B |
| September 18, 2024 | 21.82B |
| September 17, 2024 | 21.30B |
| September 16, 2024 | 21.62B |
| September 13, 2024 | 21.50B |
| September 12, 2024 | 22.32B |
| September 11, 2024 | 22.50B |
| September 10, 2024 | 22.41B |
| September 09, 2024 | 22.62B |
| September 06, 2024 | 22.19B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
16.62B
Minimum
Apr 15 2024
34.22B
Maximum
Jun 01 2020
26.96B
Average
27.96B
Median
Market Cap Benchmarks
| Pfizer Inc | 140.48B |
| Takeda Pharmaceutical Co Ltd | 43.20B |
| Nxera Pharma Co Ltd | 723.88M |
| PeptiDream Inc | 2.203B |
| Healios KK | 135.20M |
Market Cap Related Metrics
| PE Ratio | 183.47 |
| PS Ratio | 1.689 |
| Price to Book Value | 1.788 |
| Price | 10.70 |
| Earnings Yield | 0.54% |
| Operating PE Ratio | 186.91 |
| Normalized PE Ratio | 392.53 |